Ignite Creation Date:
2024-05-06 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 2:13 PM
Study NCT ID:
NCT05035446
Status:
UNKNOWN
Last Update Posted:
2021-10-11
First Post:
2021-08-26
Brief Title:
Short-term Outcomes of SILS1 Versus CLS for Distal Gastric Cancer
Sponsor:
Fujian Cancer Hospital
Organization:
Fujian Cancer Hospital
Study Overview
Official Title:
A Prospective Randomized Controlled Study of the Short-term Efficacy of Single-hole Plus One-hole Total Laparoscopic Surgery Versus Five-hole Total Laparoscopic Surgery for Distal Gastric Cancer
Status:
UNKNOWN
Status Verified Date:
2021-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the short-term outcomes of single-incision plus one-port laparoscopic surgery SILS 1 versus conventional laparoscopic surgeryCLS for distal gastric cancer whose clinical stage was cT1-3N0-2M0
Detailed Description:
The gastric cancer patients with cT1-3N0-2M0 were randomized at a 11 ratio to the CLS group or the SILS1group then it will evaluate the short-term outcomes between two groups
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None